Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at SEK 199.9B, ahead of Merck & Co (SEK 147.7B) and Novartis (SEK 116B). Figures as of 18 Nov 2026, 22:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSEK 199.9B
- Median
- SEK 5.8B
- Combined market value
- SEK 51.3T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SEK 199.9B | SEK 6.66T | SEK 2,765.38 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | SEK 147.7B | SEK 3.44T | SEK 1,397.19 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | SEK 116B | SEK 2.97T | SEK 1,573.94 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | SEK 103.5B | SEK 1.23T | SEK 603.98 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SEK 86.4B | SEK 1.83T | SEK 1,059.50 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | SEK 86.2B | SEK 1.15T | SEK 477.83 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | SEK 73.7B | SEK 12.49T | SEK 14,022.09 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | SEK 57.9B | SEK 2.81T | SEK 1,812.76 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | SEK 53B | SEK 5.13T | SEK 2,900.35 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | SEK 51.6B | SEK 1.38T | SEK 5,439.99 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | SEK 46.1B | SEK 467.5B | SEK 4,092.80 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | SEK 45.7B | SEK 987.5B | SEK 492.64 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | SEK 39.8B | SEK 1.76T | SEK 399.85 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | SEK 37.8B | SEK 689.1B | SEK 215.69 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 36.1B | SEK 499.7B | SEK 428.24 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | SEK 31.6B | SEK 991.9B | SEK 9,588.36 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | SEK 23.4B | SEK 352.6B | SEK 867.74 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | SEK 17.4B | SEK 318.7B | SEK 516.87 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | SEK 16.8B | SEK 202.9B | SEK 1,515.03 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | SEK 15.8B | SEK 249.3B | SEK 5,854.65 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | SEK 14.4B | SEK 284.6B | SEK 392.75 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 14.1B | SEK 161.3B | SEK 2,512.57 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | SEK 13.4B | SEK 235.8B | SEK 205.65 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SEK 13.3B | SEK 120.7B | SEK 622.95 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | SEK 11.6B | SEK 1.62T | SEK 284.55 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | SEK 10B | SEK 51B | SEK 610.78 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | SEK 9.3B | SEK 58.5B | SEK 85.89 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | SEK 9.1B | SEK 32B | SEK 164.79 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | SEK 6.9B | SEK 179.8B | SEK 2,741.34 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | SEK 6.3B | SEK 400.4B | SEK 696.36 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | SEK 5.8B | SEK 74.4B | SEK 850.10 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | SEK 5.8B | SEK 154.1B | SEK 791.08 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | SEK 5.5B | SEK 135.3B | SEK 270.76 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | SEK 5.2B | SEK 266.5B | SEK 1,214.86 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | SEK 3.9B | SEK 79.8B | SEK 475.09 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | SEK 3.8B | SEK 46.3B | SEK 277.75 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | SEK 3.6B | SEK 86.5B | SEK 3,094.85 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | SEK 3.6B | SEK 64.3B | SEK 1,584.29 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SEK 3.3B | SEK 71.5B | SEK 1,358.86 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | SEK 3.2B | SEK 49.1B | SEK 282.01 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | SEK 3B | SEK 61.2B | SEK 937.92 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | SEK 2.9B | SEK 77.3B | SEK 221.88 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | SEK 2.6B | SEK 40.4B | SEK 295.30 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 2.3B | SEK 61.8B | SEK 437.17 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | SEK 2.3B | SEK 85.2B | SEK 106.48 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 2B | SEK 93.8B | SEK 4,036.82 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | SEK 1.8B | SEK 60.6B | SEK 3,029.14 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 1.7B | SEK 75.7B | SEK 963.88 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 1.7B | SEK 126.6B | SEK 151.91 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | SEK 1.3B | SEK 84.2B | SEK 1,289.50 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | SEK 1.2B | SEK 72.5B | SEK 520.42 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | SEK 1.2B | SEK 75.2B | SEK 687.44 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SEK 943.4M | SEK 48.9B | SEK 509.47 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SEK 869.3M | SEK 97.7B | SEK 1,028.88 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | SEK 802.6M | SEK 101.3B | SEK 670.51 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | SEK 748.4M | SEK 49B | SEK 139.54 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | SEK 620.1M | SEK 45.9B | SEK 419.52 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 550.7M | SEK 83.7B | SEK 1,207.15 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | SEK 518.1M | SEK 48B | SEK 851.62 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | SEK 476M | SEK 65.8B | SEK 970.87 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | SEK 220.7M | SEK 53.4B | SEK 1,266.17 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1407 SEK).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (SEK 199.9B), Merck & Co (SEK 147.7B) and Novartis (SEK 116B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 22:08 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of SEK 51.3T as of 18 Nov 2026, 22:08 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.